tirzepatide patent status attorney: Novo Nordisk must use FDA in fight against compounders As Novo's patent expires, GLP-1

The patient assistance program (PAP) is for U.S

Commercial availability would follow FDA approval, likely in early 2028

Rated 5 out of 5 Randi H

To remove bubbles, gently tap the side of the syringe barrel with your fingernail

Last reviewed: June 22, 2026 Last updated: June 22, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

This certification is particularly relevant for pharmacies that work with telehealth providers and online prescription services, as it signals to partner platforms that the pharmacy meets compliance standards